Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06295770
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-02-29
Brief Title:
Obinutuzumab in Treatment of Fibrillary Glomerulonephritis
Sponsor:
Organization:
Mayo Clinic